Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India flag India · Delayed Price · Currency is INR
545.40
+20.95 (3.99%)
At close: Apr 15, 2026

BOM:544222 Revenue

Akums Drugs and Pharmaceuticals had revenue of 11.60B INR in the quarter ending December 31, 2025, with 14.76% growth. This brings the company's revenue in the last twelve months to 42.60B, up 6.22% year-over-year. In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B, down -1.45%.

Revenue (ttm)
42.60B
Revenue Growth
+6.22%
P/S Ratio
1.96
Revenue / Employee
5.65M
Employees
7,536
Market Cap
83.49B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202541.21B-605.31M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 202127.26B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jubilant Pharmova79.18B
Granules India50.92B
AstraZeneca Pharma India21.77B
Caplin Point Laboratories20.92B
FDC Limited20.78B
Sanofi India18.37B
Viyash Scientific18.17B
Rubicon Research15.98B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News